Page last updated: 2024-12-11

4-coumaroyl-coenzyme a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-coumaroyl-coenzyme A: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trans-4-coumaroyl-CoA : A 4-coumaroyl-CoA in which the double bond of the coumaroyl group has trans-geochemistry. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

4-coumaroyl-CoA : The S-(4-coumaroyl) derivative of coenzyme A. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

4-hydroxycinnamoyl-CoA: thioester substrate of medium chain acyl-CoA dehydrogenase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-coumaroyl-CoA(4-) : Tetraanion of 4-coumaroyl-CoA arising from deprotonation of phosphate and diphosphate functions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

trans-4-coumaroyl-CoA(4-) : An acyl-CoA(4-) oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of trans-4-coumaroyl-CoA; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6440013
CHEMBL ID250086
CHEBI ID15499
CHEBI ID85531
SCHEMBL ID320157
SCHEMBL ID23924211
MeSH IDM0163454
PubMed CID45266584
CHEBI ID57355
CHEBI ID85008
MeSH IDM0163454

Synonyms (40)

Synonym
4-coumaroyl-coenzyme a
3'-phosphoadenosine 5'-{3-[(3r)-3-hydroxy-4-({3-[(2-{[3-(4-hydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
CHEBI:15499
p-coumaroyl-coa ,
C00223 ,
119785-99-8
4-coumaroyl-coa
trans-4-coumaroyl-coa
CHEMBL250086
chebi:85531 ,
s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (e)-3-(4-hydroxyphenyl)prop-2-enethioate
coenzyme a, 4-coumaroyl-
unii-s9s49n6er4
s9s49n6er4 ,
coenzyme a, s-(3-(4-hydroxyphenyl)-2-propenoate), (e)-
coumaroyl-coa
SCHEMBL320157
trans-4-coumaroyl-coenzyme a
(e)-4-coumaroyl-coenzyme a
3'-phosphoadenosine 5'-{3-[(3r)-3-hydroxy-4-({3-[(2-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
LMFA07050265
s-{(3s,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (2e)-3-(4-hydroxypheny
Q2998866
p-coumaryl-coenzyme a
(e)-s-(2-(3-((2r)-4-(((((((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)-2-hydroxy-3,3-dimethylbutanamido)propanamido)ethyl) 3-(4-hydroxyphenyl)prop-2-enethio
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-3-[2-[2-[(e)-3-(4-hydroxyphenyl)prop-2-enoyl]sulfanylethylcarbamoyl]ethylcarbamoyl]-2,2-dimethyl-propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
SCHEMBL23924211
DTXSID001028841
coenzyme a, s-[(2e)-3-(4-hydroxyphenyl)-2-propenoate]
(e)-p-coumaroyl-coa
4-coumaroyl-coa(4-)
CHEBI:57355
3'-phosphonatoadenosine 5'-{3-[(3r)-3-hydroxy-4-({3-[(2-{[3-(4-hydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate}
(e)-4-coumaroyl-coa
4-hydroxycinnamoyl-coa
4-coumaryl-coa
p-coumaryl-coa
trans-4-coumaroyl-coa(4-)
CHEBI:85008
Q27158285
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
4-coumaroyl-CoAThe S-(4-coumaroyl) derivative of coenzyme A.
acyl-CoA(4-)An acyl-CoA oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of any acyl-CoA; major species at pH 7.3.
4-coumaroyl-CoA(4-)Tetraanion of 4-coumaroyl-CoA arising from deprotonation of phosphate and diphosphate functions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (55)

PathwayProteinsCompounds
Flavonoid Biosynthesis1150
Stilbenoid, Diarylheptanoid, and Gingerol Biosynthesis417
simple coumarins biosynthesis2221
spermidine hydroxycinnamic acid conjugates biosynthesis414
naringenin biosynthesis (engineered)314
flavonoid di-C-glucosylation022
simplecoumarins biosynthesis620
anthocyanidin acylglucoside and acylsambubioside biosynthesis320
aromatic polyketides biosynthesis26
chlorogenic acid biosynthesis I615
curcuminoid biosynthesis419
rosmarinic acid biosynthesis I130
chlorogenic acid biosynthesis II210
hydroxycinnamic acid serotonin amides biosynthesis017
raspberry ketone biosynthesis012
flavonol acylglucoside biosynthesis I - kaempferol derivatives09
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)231
resveratrol biosynthesis09
flavonoid biosynthesis (in equisetum)019
shisonin biosynthesis117
pelargonidin conjugates biosynthesis223
coumarins biosynthesis (engineered)628
rosmarinic acid biosynthesis II023
xanthohumol biosynthesis216
phenylpropanoid biosynthesis1628
4-hydroxybenzoate biosynthesis III (plants)115
6-gingerol analog biosynthesis (engineered)220
phenylphenalenone biosynthesis112
superpathway of rosmarinic acid biosynthesis140
anthocyanidin modification (Arabidopsis)816
hordatine biosynthesis113
hydroxycinnamic acid tyramine amides biosynthesis021
hinokiresinol biosynthesis24
phloridzin biosynthesis212
superpathway of flavones and derivatives biosynthesis1744
flavonol acylglucoside biosynthesis III - quercetin derivatives08
flavonol acylglucoside biosynthesis II - isorhamnetin derivatives07
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)519
kaempferol triglucoside biosynthesis010
phaselate biosynthesis314
flavonoid biosynthesis819
umbelliferone biosynthesis113
Representative anthocyanin biosynthetic pathway87
Flavonoid biosynthesis019
Flavonoid pathway06
Flavonoid biosynthesis119
Serotonin biosynthesis112
Lignin biosynthesis221
Resveratrol biosynthesis16
4-hydroxybenzoate biosynthesis I (eukaryotes)018
fatty acid u03B2-oxidation IV (unsaturated, even number)07
fatty acid u03B2-oxidation V (unsaturated, odd number, di-isomerase-dependent)06
fatty acid u03B2-oxidation II (plant peroxisome)016
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
avenanthramide biosynthesis021
4-hydroxybenzoate biosynthesis119
flavonol acylglucoside biosynthesis II - isorhamnetin derivatives013
rosmarinic acid biosynthesis I334
rosmarinic acid biosynthesis II122
umbelliferone biosynthesis114
coumarins biosynthesis (engineered)831
6-gingerol analog biosynthesis (engineered)420
superpathway of rosmarinic acid biosynthesis243
L-tyrosine degradation V (Stickland reaction)314
4-coumarate degradation (aerobic)517
hinokiresinol biosynthesis28
4-hydroxybenzoate biosynthesis III (plants)116
hordatine biosynthesis114
spermidine hydroxycinnamic acid conjugates biosynthesis315
phenylpropanoid biosynthesis1229
resveratrol biosynthesis111
raspberry ketone biosynthesis212
phenylphenalenone biosynthesis115
aromatic polyketides biosynthesis27
superpathway of flavones and derivatives biosynthesis1064
pelargonidin conjugates biosynthesis225
anthocyanidin acylglucoside and acylsambubioside biosynthesis327
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)424
shisonin biosynthesis120
anthocyanidin modification (Arabidopsis)820
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)233
flavonoid biosynthesis823
flavonoid di-C-glucosylation029
naringenin biosynthesis (engineered)415
flavonol acylglucoside biosynthesis III - quercetin derivatives014
flavonol acylglucoside biosynthesis I - kaempferol derivatives015
4-coumarate degradation414

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyketide synthase BASRheum palmatumKm10.000010.000010.000010.0000AID307197
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID307197Activity of Rheum palmatum benzalacetone synthase2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Structure function analysis of benzalacetone synthase from Rheum palmatum.
AID307196Activity of Rheum palmatum benzalacetone synthase S338V mutant2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Structure function analysis of benzalacetone synthase from Rheum palmatum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.27)18.7374
1990's2 (4.55)18.2507
2000's18 (40.91)29.6817
2010's19 (43.18)24.3611
2020's4 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.56 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]